Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.

ABSTRACT: Triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere^®; SCS triamcinolone acetonide) is a corticosteroid approved in the USA for the treatment of macular edema associated with uveitis. Suprachoroidal injection of SCS triamcinolone acetonide results in preferential distribution into the posterior segment, which may reduce the risk of corticosteroid-related adverse events, such as cataracts and intraocular pressure (IOP) elevation. In a multicenter phase III trial in patients with non-infectious uveitic macular edema, SCS triamcinolone acetonide significantly and rapidly improved visual acuity and reduced signs of macular edema compared with sham treatment. SCS triamcinolone acetonide was generally well tolerated, with the most common adverse event being eye

SUBMITTER: Fung S 

PROVIDER: S-EPMC9512860 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature